Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Sprick

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|October 3, 2018
Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancerSarah F Jauch, Sabine Riethdorf, Martin R Sprick, et al.
International Journal of Cancer|February 28, 2025
Biopsy-derived organoids in personalised early breast cancer care: Challenges of tumour purity and normal cell overgrowth cap their practical utilityPaul Schwerd-Kleine, Roberto Würth, Tasneem Cheytan, et al.
Pancreas|September 26, 2025
Proteomic Characterization Reveals CYP2S1 as a Mediator of Drug Resistance in PDACVera Thiel, Wiebke M Nadler, Alexander Kerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2017
Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment ResponseAlexander Muckenhuber, Anne Katrin Berger, Anna Melissa Schlitter, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2018
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumorsMagdolna Djurec, Osvaldo Graña, Albert Lee, et al.
Oncoimmunology|January 27, 2017
Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinomaIsabel Poschke, Marta Faryna, Frank Bergmann, et al.
Science Translational Medicine|September 13, 2021
Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasisMahak Singhal, Nicolas Gengenbacher, Ashik Ahmed Abdul Pari, et al.
Gastroenterology|March 2, 2010
Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cellsFrederik J H Hoogwater, Maarten W Nijkamp, Niels Smakman, et al.
Cell Reports|May 31, 2023
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancerMassimo Saini, Laura Schmidleitner, Helena Domínguez Moreno, et al.
Cell|July 4, 2015
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerFelix Dietlein, Bastian Kalb, Mladen Jokic, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|October 3, 2018
Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancerSarah F Jauch, Sabine Riethdorf, Martin R Sprick, et al.
International Journal of Cancer|February 28, 2025
Biopsy-derived organoids in personalised early breast cancer care: Challenges of tumour purity and normal cell overgrowth cap their practical utilityPaul Schwerd-Kleine, Roberto Würth, Tasneem Cheytan, et al.
Pancreas|September 26, 2025
Proteomic Characterization Reveals CYP2S1 as a Mediator of Drug Resistance in PDACVera Thiel, Wiebke M Nadler, Alexander Kerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2017
Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment ResponseAlexander Muckenhuber, Anne Katrin Berger, Anna Melissa Schlitter, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2018
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumorsMagdolna Djurec, Osvaldo Graña, Albert Lee, et al.
Oncoimmunology|January 27, 2017
Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinomaIsabel Poschke, Marta Faryna, Frank Bergmann, et al.
Science Translational Medicine|September 13, 2021
Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasisMahak Singhal, Nicolas Gengenbacher, Ashik Ahmed Abdul Pari, et al.
Gastroenterology|March 2, 2010
Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cellsFrederik J H Hoogwater, Maarten W Nijkamp, Niels Smakman, et al.
Cell Reports|May 31, 2023
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancerMassimo Saini, Laura Schmidleitner, Helena Domínguez Moreno, et al.
Cell|July 4, 2015
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerFelix Dietlein, Bastian Kalb, Mladen Jokic, et al.
Pageof 5